Triomics Raises $22M for Oncology AI Expansion

Triomics raises $22 million in Series B financing to scale AI for early cancer detection and treatment. The funding is led by Battery Ventures with participation from Nexus Venture Partners, Lightspeed, Y Combinator, Oncology Ventures, and Precision Health Informatics. The company supports cancer centers in operationalizing clinical data. This investment targets the $250 billion US oncology market where AI adoption is most challenging.